Skin‐Reducing Mastectomy and Implant Reconstruction: Long‐Term Surgical, Oncological, and Patient‐Reported Outcomes
ANZ Journal of Surgery · 2026-01 · 96 (1-2) · 125-137
DOI: 10.1111/ans.70485 ↗Kurz gefasst
Fachartikel in der Zeitschrift ANZ Journal of Surgery, online erschienen am 23.01.2026. Verfasst von Gaik Si Quah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Westmead Breast Cancer Institute, Westmead Hospital, Westmead, New South Wales, Australia. Hauptthemen laut MEDLINE: Breast Neoplasms, Mammaplasty, Mastectomy, Breast Implantation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Skin‐reducing mastectomy (SRM) allows implant‐based immediate breast reconstruction in women with large, ptotic breasts. This study aimed to evaluate the surgical and patient‐reported outcomes (PRO) following SRM.
Methods
A retrospective analysis was conducted on patients who underwent SRM between January 2011 and December 2014. Surgical complications, oncological outcomes, and PRO (using BREAST‐Q) were collected, with a median follow‐up of 10 years.
Results
Fifty‐five women (95 breasts) underwent SRM and completed the first round of the BREAST‐Q questionnaire. 82.3% ( n = 45) had SRM for cancer treatment, and the remaining had risk‐reducing surgery. 83.6% ( n = 46) had direct‐to‐implant reconstruction, and the remainder had a tissue expander inserted. The mean breast weight was 714 g, and the mean implant volume was 398 mL. The overall complication rate was 58.9%. The most common complication was skin loss due to flap/skin necrosis (24.2%), followed by capsular contracture (18.9%), seroma (7.4%), wound dehiscence (5.3%), implant infection (2.1%), and bleeding (1%). The early implant loss rate was 10.5%. At 10 years ( n = 17), the local recurrence rate was 4.4%, the overall survival rate was 97.7%, and the disease‐free survival rate was 88.9%. Breast‐Q scores were comparable to previous studies (mean score of 65.33). 30.9% of patients ( n = 17) completed the modified BREAST‐Q questionnaire at 10 years of follow‐up. Reconstructed breast satisfaction was high, and 76.5% of patients would choose to undergo SRM again if given the option.
Conclusion
In certain patients with larger breasts, SRM can facilitate implant‐based immediate breast reconstruction without the need for mesh. Despite relatively high complication rates, patient satisfaction remains high.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Westmead Breast Cancer Institute, Westmead Hospital, Westmead, New South Wales, Australia.
- Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, New South Wales, Australia.
ORCID-Profile: Gaik Si Quah
Zitieren
APA
Quah, G. S., Brennan, M., French, J., & Elder, E. (2026). Skin‐Reducing Mastectomy and Implant Reconstruction: Long‐Term Surgical, Oncological, and Patient‐Reported Outcomes. ANZ Journal of Surgery, 96(1-2), 125-137. https://doi.org/10.1111/ans.70485
Vancouver
Quah GS, Brennan M, French J, Elder E. Skin‐Reducing Mastectomy and Implant Reconstruction: Long‐Term Surgical, Oncological, and Patient‐Reported Outcomes. ANZ Journal of Surgery. 2026;96(1-2):125-137. doi:10.1111/ans.70485
BibTeX
@article{Quah2026,
author = {Quah, Gaik Si and Brennan, Meagan and French, James and Elder, Elisabeth},
title = {Skin‐Reducing Mastectomy and Implant Reconstruction: Long‐Term Surgical, Oncological, and Patient‐Reported Outcomes},
journal = {ANZ Journal of Surgery},
year = {2026},
volume = {96},
number = {1-2},
pages = {125--137},
doi = {10.1111/ans.70485}
}
EUVIMED